Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology

by Alexandra A. Alario, Mark J. Niciu
Published 2021-05-01

Neurophysiological Correlates and Differential Drug Response in Subjects With a Family History of an Alcohol Use Disorder

by Sage M. Comstock, Jatin G. Vaidya, Mark J. Niciu
Published 2019-08-01

Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease

by Mark J. Niciu, Xin-Ming Ma, Rajaâ El Meskini, Joel S. Pachter, Richard E. Mains, Betty A. Eipper
Published 2007-09-01

Biomarkers in mood disorders research: developing new and improved therapeutics

by MARK J. NICIU, DANIEL C. MATHEWS, DAWN F. IONESCU, ERICA M. RICHARDS, MAURA L. FUREY, PEIXIONG YUAN, ALLISON C. NUGENT, IOLINE D. HENTER, RODRIGO MACHADO-VIEIRA, CARLOS A. ZARATE JR
Published 2014-01-01

Lithium and Valproate Levels Do Not Correlate with Ketamine’s Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

by Annie J. Xu, Mark J. Niciu, Nancy B. Lundin, David A. Luckenbaugh, Dawn F. Ionescu, Erica M. Richards, Jennifer L. Vande Voort, Elizabeth D. Ballard, Nancy E. Brutsche, Rodrigo Machado-Vieira, Carlos A. Zarate
Published 2015-01-01

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

by Erica M. Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, Laura Newman, Cristan Farmer, Elizabeth D. Ballard, Rodrigo Machado-Vieira, Peixiong Yuan, Mark J. Niciu, Chul Hyoung Lyoo, Ioline D. Henter, Giacomo Salvadore, Wayne C. Drevets, Hartmuth Kolb, Robert B. Innis, Carlos A. Zarate Jr
Published 2018-07-01